ホーム4DX • ASX
add
4DMedical Ltd
市場ニュース
財務情報
損益計算書
収益
純利益
(AUD) | 2024年6月info | 前年比変化率 |
---|---|---|
収益 | 148.09万 | 1,172.70% |
営業費用 | 1256.17万 | 11.42% |
純利益 | -1018.61万 | -33.78% |
純利益率 | -687.84 | 89.49% |
1 株当たりの収益 | — | — |
EBITDA | -1109.48万 | -5.51% |
実効税率 | -0.01% | — |
貸借対照表
総資産
負債総額
(AUD) | 2024年6月info | 前年比変化率 |
---|---|---|
現金および短期投資 | 3060.61万 | -56.01% |
総資産 | 1.20億 | 29.16% |
負債総額 | 4908.88万 | 128.71% |
純資産 | 7092.66万 | — |
発行済み株式 | 4.11億 | — |
帳簿価格 | 3.32 | — |
総資産利益率 | -23.28% | — |
資本利益率 | -36.73% | — |
キャッシュ フロー
現金の純増減額
(AUD) | 2024年6月info | 前年比変化率 |
---|---|---|
純利益 | -1018.61万 | -33.78% |
営業キャッシュ フロー | -806.31万 | 8.54% |
投資キャッシュ フロー | -33.95万 | -21.29% |
財務キャッシュ フロー | -23.40万 | -101.11% |
現金の純増減額 | -863.66万 | -172.48% |
フリー キャッシュ フロー | -543.18万 | 13.25% |
概要
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
設立
2013
ウェブサイト
従業員数
145